Pneumocystis carinii Pneumonia During Maintenance Anti–Tumor Necrosis Factor-α Therapy with Infliximab for Crohn’s Disease
2004; Oxford University Press; Volume: 10; Issue: 5 Linguagem: Inglês
10.1097/00054725-200409000-00025
ISSN1536-4844
AutoresFernando Velayos, William J. Sandborn,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoBackgroundClinical trials using infliximab have not reported cases of Pneumocystis carinii pneumonia (PCP), and PCP infection during standard medical treatment of inflammatory bowel disease is uncommon. Postmarketing surveillance through June of 2001 has identified 10 cases of PCP occurring during treatment with infliximab; 3 patients died.
Referência(s)